Cargando…

Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis

OBJECTIVES: Although guidelines recommend extended cholecystectomy for T2 gallbladder cancer (GBC), the optimal hepatectomy strategy remains controversial. The study aims to compare the prognosis of T2 GBC patients who underwent wedge resection (WR) versus segment IVb and V resection (SR) of the liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhehan, Yu, Jiayu, Cao, Jiasheng, Lin, Chenping, Hu, Jiahao, Zhang, Bin, Shen, Jiliang, Feng, Xu, Topatana, Win, Chen, Mingyu, Fang, Haixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352769/
https://www.ncbi.nlm.nih.gov/pubmed/37469411
http://dx.doi.org/10.3389/fonc.2023.1186378
_version_ 1785074581349859328
author Chen, Zhehan
Yu, Jiayu
Cao, Jiasheng
Lin, Chenping
Hu, Jiahao
Zhang, Bin
Shen, Jiliang
Feng, Xu
Topatana, Win
Chen, Mingyu
Fang, Haixing
author_facet Chen, Zhehan
Yu, Jiayu
Cao, Jiasheng
Lin, Chenping
Hu, Jiahao
Zhang, Bin
Shen, Jiliang
Feng, Xu
Topatana, Win
Chen, Mingyu
Fang, Haixing
author_sort Chen, Zhehan
collection PubMed
description OBJECTIVES: Although guidelines recommend extended cholecystectomy for T2 gallbladder cancer (GBC), the optimal hepatectomy strategy remains controversial. The study aims to compare the prognosis of T2 GBC patients who underwent wedge resection (WR) versus segment IVb and V resection (SR) of the liver. METHODS: A specific search of online databases was performed from May 2001 to February 2023. The postoperative efficacy outcomes were synthesized and meta-analyses were conducted. RESULTS: A total of 9 studies involving 2,086 (SR = 627, WR = 1,459) patients were included in the study. The primary outcomes included disease-free survival (DFS) and overall survival (OS). For DFS, the 1-year DFS was statistically higher in patients undergoing SR than WR [risk ratio (RR) = 1.07, 95% confidence interval (CI) = 1.02-1.13, P = 0.007]. The 3-year DFS (P = 0.95), 5-year DFS (P = 0.77), and hazard ratio (HR) of DFS (P = 0.72) were similar between the two groups. However, the 3-year OS was significantly lower in patients who underwent SR than WR [RR = 0.90, 95% CI = 0.82-0.99, P = 0.03]. Moreover, SR had a higher hazard HR of OS [HR = 1.33, 95% CI = 1.01-1.75, P = 0.04]. No significant difference was found in 1-year (P = 0.32) and 5-year (P = 0.9) OS. For secondary outcomes, patients who received SR tended to develop postoperative complications (POC) [RR = 1.90, 95% CI = 1.00-3.60, P = 0.05]. In addition, no significant differences in intrahepatic recurrence (P = 0.12) were observed. CONCLUSIONS: In conclusion, SR can improve the prognosis of T2 GBC patients in DFS. In contrast to WR, the high HR and complications associated with SR cannot be neglected. Therefore, surgeons should evaluate the condition of the patients and take their surgical skills into account when selecting SR. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier, CRD42022362974.
format Online
Article
Text
id pubmed-10352769
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103527692023-07-19 Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis Chen, Zhehan Yu, Jiayu Cao, Jiasheng Lin, Chenping Hu, Jiahao Zhang, Bin Shen, Jiliang Feng, Xu Topatana, Win Chen, Mingyu Fang, Haixing Front Oncol Oncology OBJECTIVES: Although guidelines recommend extended cholecystectomy for T2 gallbladder cancer (GBC), the optimal hepatectomy strategy remains controversial. The study aims to compare the prognosis of T2 GBC patients who underwent wedge resection (WR) versus segment IVb and V resection (SR) of the liver. METHODS: A specific search of online databases was performed from May 2001 to February 2023. The postoperative efficacy outcomes were synthesized and meta-analyses were conducted. RESULTS: A total of 9 studies involving 2,086 (SR = 627, WR = 1,459) patients were included in the study. The primary outcomes included disease-free survival (DFS) and overall survival (OS). For DFS, the 1-year DFS was statistically higher in patients undergoing SR than WR [risk ratio (RR) = 1.07, 95% confidence interval (CI) = 1.02-1.13, P = 0.007]. The 3-year DFS (P = 0.95), 5-year DFS (P = 0.77), and hazard ratio (HR) of DFS (P = 0.72) were similar between the two groups. However, the 3-year OS was significantly lower in patients who underwent SR than WR [RR = 0.90, 95% CI = 0.82-0.99, P = 0.03]. Moreover, SR had a higher hazard HR of OS [HR = 1.33, 95% CI = 1.01-1.75, P = 0.04]. No significant difference was found in 1-year (P = 0.32) and 5-year (P = 0.9) OS. For secondary outcomes, patients who received SR tended to develop postoperative complications (POC) [RR = 1.90, 95% CI = 1.00-3.60, P = 0.05]. In addition, no significant differences in intrahepatic recurrence (P = 0.12) were observed. CONCLUSIONS: In conclusion, SR can improve the prognosis of T2 GBC patients in DFS. In contrast to WR, the high HR and complications associated with SR cannot be neglected. Therefore, surgeons should evaluate the condition of the patients and take their surgical skills into account when selecting SR. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier, CRD42022362974. Frontiers Media S.A. 2023-07-04 /pmc/articles/PMC10352769/ /pubmed/37469411 http://dx.doi.org/10.3389/fonc.2023.1186378 Text en Copyright © 2023 Chen, Yu, Cao, Lin, Hu, Zhang, Shen, Feng, Topatana, Chen and Fang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Chen, Zhehan
Yu, Jiayu
Cao, Jiasheng
Lin, Chenping
Hu, Jiahao
Zhang, Bin
Shen, Jiliang
Feng, Xu
Topatana, Win
Chen, Mingyu
Fang, Haixing
Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis
title Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis
title_full Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis
title_fullStr Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis
title_full_unstemmed Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis
title_short Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis
title_sort wedge resection versus segment ivb and v resection of the liver for t2 gallbladder cancer: a systematic review and meta-analysis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352769/
https://www.ncbi.nlm.nih.gov/pubmed/37469411
http://dx.doi.org/10.3389/fonc.2023.1186378
work_keys_str_mv AT chenzhehan wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis
AT yujiayu wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis
AT caojiasheng wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis
AT linchenping wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis
AT hujiahao wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis
AT zhangbin wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis
AT shenjiliang wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis
AT fengxu wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis
AT topatanawin wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis
AT chenmingyu wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis
AT fanghaixing wedgeresectionversussegmentivbandvresectionoftheliverfort2gallbladdercancerasystematicreviewandmetaanalysis